This implies that individuals or populations inhabiting different environments will be subject to sexual selection on male colour pattern in different directions, without any evolved change in female preferences.
The authors also report that the effectiveness of achromatic components of colour pattern changed much less with light environment than did that of chromatic colours. Although perhaps unsurprising, this observation allowed the authors to hypothesize that chromatic and achromatic colours evolve in qualitatively different ways, with the latter representing some form of contingency against environmental change. Species living in a range of light environments (generalists) would be more likely to evolve achromatic colours for signalling, whereas species that specialize on certain microhabitats would combine chromatic and achromatic components. In both of these groups, achromatic colour elements might function in aspects of communication that must work across multiple light environments -for example, the light differs on the breeding and feeding grounds of many fishes. Consequently, the authors predict that the evolution of chromatic and achromatic signals would show different levels of evolutionary conservation.
These are interesting ideas for how microevolutionary processes (those within a population) allow predictions to be made about macroevolutionary (between-species) patterns. Although testing such predictions in guppies may be difficult owing to the absence of macroevolutionary radiations in this lineage 14 , support comes from work on other fishes. In African cichlid fishes, of which there are large species radiations, chromatic colours tend to vary between closely related species, whereas arrangements of black stripes and bars are more strictly conserved 16 ( Fig. 1) . And evolutionary diversification into many species that have different chromatic male courtship colours is associated with microhabitat specialization, whereas such diversification is not typically seen in habitat generalists.
The comparison between guppies and cichlids is interesting from yet other perspectives. Guppies are one of the few animals in which the genetic correlation between female preference and male trait, theoretically predicted by Fisher 3 and by most models of sexual selection, has been demonstrated 17 . One would expect this co-evolution between the sexes to lead, at least sometimes, to behaviourally isolated species, but this has almost never happened in guppies. Ecological constraints 14 and continued gene flow as a result of male coercion 15 are two possible explanations, but implicit in the work of Cole and Endler is a third one: that the co-evolutionary mosaic between male colour and female preference is often mediated by environmental variation in light on so small a spatial scale that it facilitates individual variation within populations but no divergence between populations (Fig. 1) . Guppies live in shallow waters of forest streams, where bright spots of sunlight alternate with canopy shade, which is depleted in red and blue light but rich in green and yellow. Individual guppies move about in this mosaic of light, and this facilitates the evolution of large colour variation between individuals within a population (called colour polymorphism) that is associated with individual light preferences. Cichlid populations in African lakes experience variation in light on a very different spatial scale, mediated by water depth, and these long and broad light gradients facilitate the divergence of entire populations across depths, eventually leading to speciation 12 . It seems that it is the relationship between the spatial scales of light heterogeneity and individual movement that determines whether sexual selection will maintain sexualsignal variation within populations or drive loss of variation within populations, divergence between populations and speciation. ■ 
Ole Seehausen
lthough cancers originate from cellintrinsic genetic mutations, it has become clear that for malignant tumours to progress in an unrestrained fashion they must elude or subvert the host's immune system 1 . As a result, the best, and perhaps the only, option for curing cancer lies in enhancing these immunosurveillance mechanisms. This can be achieved by immunotherapiestreatments specifically designed to stimulate anticancer immunity 2,3 -and through chemotherapies and radiotherapies that mediate their long-term effects by eliciting anti cancer immunity 4 . Natural anticancer immune responses, as well as many forms of cancer immunotherapy, depend on the activity of T cells that recognize tumour-specific molecules (antigens) 1, 2 ; only rarely have anticancer effects been ascribed to the antibody-producing B cells of the humoral immune system 5 . But in this issue, Carmi et al. 6 (page 99) and Shalapour et al. 7 (page 94) reveal the potential of humoral immune responses to positively and negatively regulate T-cell-based anti cancer immunity. Animal studies have revealed that tumours from one individual typically do not grow following transplantation into another individual of the same species, in much the same way that transplanted organs are rejected by the recipient's immune system. Carmi et al. 6 reasoned that understanding this tumour rejection might provide clues to harnessing the natural antitumour immune response. They studied the reaction to tumours transplanted from mice of one strain into a strain that had the same genes encoding the major histo compatibility complex (MHC) molecules, which are the strongest determinants of transplant rejection, but that were otherwise genetically distinct. Rejection of these allogeneic tumours was triggered by antibodies that bind to tumour antigens through the antibody's 'variable' region and interact with the Fcγ receptor of dendritic cells (DCs) through its 'constant' region. The DCs then engulf portions of the tumour cells, extract their antigens and present them to specific T cells (of the cytotoxic CD8 + subset), which eventually activates the T cells to kill the cancer cells (Fig. 1a) . These tumour-specific antibodies were 'natural' antibodies that were produced by the mice without any immunization.
The authors then used several experimental approaches to show that natural allogeneic antibodies of the immunoglobulin G (IgG) class induce potent T-cell-mediated anticancer immune responses. First, systemic injection of natural IgG antibodies prevented the engraftment of tumour cells transplanted between mice that were genetically identical to one another (syngeneic) but distinct from the mice from which the antibodies were purified (allogeneic). Second, when tumour cells were coated with natural allogeneic IgG antibodies and incubated with syngeneic DCs ex vivo, the DCs extracted tumour antigens from the cells, and mice immunized with these DCs were protected against tumour formation following tumour-cell transplantation. Third, injection of allogeneic IgG antibodies directly into established mouse tumours (breast, pancreatic and lung tumours, and melanomas), in combination with adjuvant compounds that activate tumour-associated DCs, induced an immune response that eradicated the tumours. Remarkably, this latter protocol not only removed the primary tumour but also eradicated secondary (metastatic) tumours in distant organs. The authors also provide evidence suggesting that the anticancer effects induced by allogeneic IgG antibodies are ultimately mediated by CD8 + T cells targeting tumour antigens. It remains to be determined whether this approach could be used to treat human cancers. Such attempts would involve pooling IgG antibodies from healthy individuals for direct injection into the tumours of patients, together with adjuvants. This principle could first be assessed in tumour explants incubated with allogeneic IgG antibodies from different individuals.
However, the contribution of B cells to anticancer immunity is not always positive. Shalapour et al. 7 provide evidence that a subpopulation of B cells suppresses the activation of tumour-targeting CD8 + T cells in prostate cancers treated with the drug oxaliplatin (Fig. 1b) . Oxaliplatin is a chemotherapeutic agent that not only kills cancer cells but also stimulates antitumour immune responses, inducing cancer-cell stress and death in a way that allows DCs to take up the tumour antigens and present them to tumour-specific CD8 + T cells 8, 9 . Shalapour and colleagues find that oxaliplatin induces both T cells and B cells to infiltrate the tumour, and that deleting B cells improves T-cell infiltration, thereby improving the effectiveness of the treatment at retarding tumour growth. They show that the B cells responsible for these effects express IgA antibodies and produce the immunosuppressive signalling molecule interleukin-10. After oxaliplatin treatment, these B cells also express the surface molecule PD-L1, the ligand of the PD-1 receptor that is expressed on T cells and can paralyse their function if bound.
Furthermore, oxaliplatin induced the expression of transforming growth factor β (TGF-β) in the tumour, which was required to attract the B cells. The authors show that mice lacking TGF-β receptor 2 in their B cells, or mice unable to secrete IgA antibodies, had reduced expression of PD-L1 on intratumoral B cells following oxaliplatin treatment, and that these mice responded better to the treatment than wild-type mice, showing a greater reduction in tumour size. Inhibiting PD-L1 with blocking antibodies in wild-type mice after oxaliplatin treatment had a similar beneficial effect.
The findings in these two papers underscore the ambiguous role of B cells and their products in tumour immunology. On the one hand, IgG antibodies that recognize tumour antigens can trigger the crucial first step of a cellular immune response: the Fcγ-mediated uptake of tumour antigens by DCs. Whether such antibodies can mediate additional anticancer functions, for instance by antibody-dependent cellular cytotoxicity, remains to be explored 10 . But on the other hand, B cells that infiltrate the tumour and produce IgA can exert local immunosuppression. At this stage, it is not clear whether the IgA antibodies secreted by these cells must specifically recognize tumour antigens to subvert cellular immunity.
Regardless of the unknowns, and the possibility that these findings are highly dependent on cancer type, these newly described roles of B cells in anticancer immunosurveillance present a promising frontier for therapeutic exploitation. Further opportunities to stimulate immune defences against malignant cells will arise as we learn more about the role of humoral immunity in cancer, including how tumour antigens are recognized by antibodies, the regulation of antibody class switching (to and from IgG and IgA isotypes), and the functional characteristics of distinct B-cell subpopulations. ■ 7 show a different role for B cells during oxaliplatin-based chemotherapy. The drug induces the intratumoral expression of transforming growth factor β (TGF-β), which causes B cells to switch to producing IgA antibodies. These IgA-producing B cells secrete the broadly immunosuppressive molecule interleukin-10 (IL-10) and express PD-L1, the ligand for the T-cell receptor PD-1. Through these functions, the B cells inhibit T-cell activity that would otherwise be stimulated by the combination of DCs presenting antigens from dying tumours and intrinsic adjuvant signals.
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R O B E R T L E G E N ST E I N
T he human brain is a network of billions of neurons that communicate through some 10 15 synaptic connections. Our cognitive abilities result from computations performed in this vast network, which is shaped by experience as learning drives changes in the strengths of synaptic coupling. Synthetic neuromorphic circuits use the same massively parallel architecture in complementary metaloxide-semiconductor (CMOS) technology, which underpins much of the circuitry in conventional computers. But designing neuromorphic chips that approach the connectivity of the human brain remains challenging. On page 61 of this issue, Prezioso et al. 1 report a major advance in the field -an artificial neural network that learns to solve a visual-recognition task on the basis of artificial synapses formed from devices called memristors.
Nearly all contemporary computational devices are based on a design known as the von Neumann architecture. The Achilles heel of this incredibly successful approach is the separation of computation and memory: although data are manipulated in the central processing unit, they are stored in a separate randomaccess memory. Any operation therefore involves the transfer of data between these components. Known as the von Neumann bottle neck 2 , this renders the computation inefficient.
An alternative model is offered by the architecture of the brain, in which computation and memory are highly intermingled. The 'program' -which includes previously observed data and memories -is stored in the strengths of synaptic connections directly adjacent to the neuronal processing units. Derivatives of this architecture, known as artificial neural networks, have been investigated since the inception of computer science 3, 4 . Artificial neural networks are not programmed like conventional computers. Just as humans learn from experience, they acquire their function from data during a training phase. Human-like performance has recently been obtained for several tasks 5 by using huge data sets to train large networks containing hundreds of millions of connections. This research has further fuelled interest in brain-inspired neuromorphic hardware that emulates neuronal computation more directly than conventional hardware in a massively parallel design. But communication between emulated neurons is a crucial factor, and so most of the chip area and power usage of neuro morphic hardware are inefficiently consumed by CMOS circuits that act as artificial synapses.
Memristors seem to offer an ideal solution to this problem 6 . These devices are resistors that have an analog memory conceptually similar to that of biological synapses. Memristor arrays can be fabricated at extremely high density, operate at ultra-low power, and capture key aspects of biological synaptic plasticity (the ability of synaptic connections to strengthen or weaken as a function of the connected neurons' activity). But using memristors as artificial synapses has proved difficult because of high device-to-device variability -even when two devices are fabricated with identical parameters, their actual behaviour can be quite different.
Enter Prezioso and colleagues. They have fabricated a memristive crossbar array consisting of a grid formed by 12 horizontal and 12 vertical metal wires, with connectors made of layers of aluminium oxide and titanium dioxide between the wires at the crosspoints. A memristor is thereby formed at every intersection of wires. The authors used this array to implement artificial synaptic connections for a simple neural network (Fig. 1) . Prezioso et al. used junction parameters (such as the layer thicknesses) that they had previously determined in exhaustive tests to minimize memristor variability. This allowed the authors to produce a crossbar without the need for additional transistors at crosspoints to compensate for variability: avoiding the use of compensatory transistors is a prerequisite for high network connectivity.
Because neural networks adapt their synaptic strengths during training, it is important that the conductance of memristors can also change during operation. Prezioso and colleagues demonstrated that their system has this capability in an experiment in which the network quickly learned to report which letter of the alphabet was shown in , which consists of crossing horizontal and vertical wires that have memristor devices (yellow) at the junctions. Input voltages V 1 to V 3 (the network inputs) drive currents through the memristors, and these currents are summed up in the vertical wires. Artificial neurons (triangles) process the difference between currents in neighbouring wires to produce outputs f 1 and f 2 . The plus and minus symbols on the neurons indicate that the output depends on current differences.
COMPUTER SCIENCE
Nanoscale connections for brain-like circuits
Tiny circuit elements called memristors have been used as connections in an artificial neural network -enabling the system to learn to recognize letters of the alphabet from imperfect images. See Letter p.61
